CYRX Earnings Date: Nov 5, 2026 (Estimated) — Cryoport, Inc.
NASDAQ · Industrials · Integrated Freight & Logistics
Updated
When is CYRX's next earnings date?
Cryoport, Inc. (CYRX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.19 on revenue of $48.7M.
How did CYRX do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Cryoport, Inc. posted EPS of -$0.20 versus the -$0.19 estimate, a miss of 5.3%. Revenue was $49.0M against a $48.2M estimate. The stock's 1-day post-earnings move was +2.8%.
How much does CYRX stock move after earnings?
CYRX beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.1% (up or down) in the day after earnings.
About Cryoport, Inc.
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.19 | -0.20 | -5.26% | $49.0M | ❌ Miss | +2.79% | +2.86% | +7.48% |
| 2026-05-04 | Q1 2026 | -0.19 | -0.25 | -31.58% | $47.8M | ❌ Miss | +19.39% | +28.99% | +61.61% |
| 2026-03-03 | Q4 2025 | -0.20 | -0.17 | +15.00% | $45.5M | ✅ Beat | +2.94% | -7.18% | +0.24% |
| 2025-11-04 | Q3 2025 | -0.21 | -0.18 | +14.29% | $44.2M | ✅ Beat | -7.48% | -4.01% | +7.16% |
| 2025-08-05 | Q2 2025 | -0.21 | -0.24 | -14.29% | $45.5M | ❌ Miss | +29.82% | +25.96% | +31.31% |
| 2025-03-04 | Q4 2024 | -0.31 | -0.42 | -35.48% | $59.5M | ❌ Miss | +30.63% | +31.42% | +21.74% |
| 2024-11-07 | Q3 2024 | -0.29 | -0.02 | +93.10% | $56.7M | ✅ Beat | -3.62% | -7.98% | +3.87% |
| 2024-08-06 | Q2 2024 | -0.39 | -0.29 | +25.64% | $57.6M | ✅ Beat | -0.26% | +5.26% | +5.39% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $49.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Service | 57.1% | $28.0M | +14.8% | $77.6M | $22.9M | $24.4M | $24.3M |
| Product | 42.9% | $21.0M | -0.4% | $39.5M | $18.2M | $21.1M | $20.0M |
By region
Q2 FY26 · $49.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Americas | 75.3% | $36.9M | +11.0% | $65.7M | $32.2M | $33.2M | $33.1M |
| EMEA | 16.4% | $8.0M | +37.7% | $45.1M | $5.6M | $5.8M | $6.6M |
| Asia Pacific | 8.3% | $4.0M | -36.6% | $31.0M | $3.3M | $6.4M | $4.5M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.